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It is often stated that vaccines may help reduce antimicrobial use in swine production. 
However, limited evidence is available outside clinical trials. We studied the change in 
amounts of antimicrobials prescribed for weaners and finishers in herds following initiation 
of vaccination against five common endemic infections: Mycoplasma hyopneumoniae, 
Actinobacillus pleuropneumoniae, porcine circovirus type II, porcine reproductive and 
respiratory syndrome virus, and Lawsonia intracellularis. Comparison was made to the 
change after a randomly selected date in herds not vaccinating against each of the 
infections. Danish sow herds initiating vaccination during 2007–2013 were included 
(69–334 herds, depending on the analysis). Danish sow herds with no use of the vaccine 
in question were included as non-exposed herds (130–570 herds, depending on the 
analysis). Antimicrobial prescriptions for weaners in sow herds and for finishers in receiv-
ing herds were extracted from the VetStat database for a period of 12 months before 
and 6–18 months after the first purchase of vaccine, or random date and quantified as 
average animal daily doses (ADDs) per 100 animals per day. The herd-level difference 
between ADD in the period after and before vaccination was the outcome in linear 
regression models for weaner pigs, and linear mixed-effects models for finishing pigs, 
taking into account sow herds delivering pigs to two or more finisher herds. Three plausi-
ble risk factors (Baseline ADD, purchase of specific vaccine, purchase of other vaccines) 
and five confounders (herd size, export and herd health status, year and season) were 
initially considered in all 10 models. The main significant effect in all models was the 
Baseline ADD; the higher the Baseline ADD was for weaner and finishing pigs, the larger 
the decrease in ADD was following vaccination (or random date for non-vaccinating 
herds). Regardless of vaccination status, almost equal proportions of herds experienced 
a decrease and an increase in ADD resulting in no overall Change in ADD. Furthermore, 
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inTrODUcTiOn
Due to its large production, the Danish pig sector accounts for 
76% of the total amount of antimicrobial substances used for 
livestock production per year in the country (1). Official focus 
on reducing antimicrobial use has, therefore, been on the pig 
production. The Danish Government and the swine industry 
have put in place several initiatives to try to mitigate the poten-
tial risk related to the development of antimicrobial-resistant 
bacteria. One of these initiatives, “the Yellow Card Scheme,” 
which identifies and warns livestock farmers using above a given 
permitted limit of antimicrobials, was introduced in 2010 and 
is managed by the Danish Veterinary Authorities. The antimi-
crobial use decreased after the introduction of the Yellow Card 
Scheme (2). From 2010 to 2014, there was a 14% reduction in 
the antimicrobial treatment proportion, measured as defined 
animal daily doses (ADDs) per 1,000 animals per day across 
the total Danish pig production (1). The pig industry’s goal is 
a further reduction by 10% before 2020 (3). To achieve this, 
relevant and effective strategies that can minimize the need for 
treatment with antimicrobials in the pig production are needed.
For animal welfare and productivity reasons, diseased 
animals should be treated. However, an increased or improved 
use of vaccination has been suggested as a potential strategy to 
prevent specific diseases and/or secondary infections (4). Today, 
the majority of Danish sows are being vaccinated against several 
pathogens as a standard procedure. On the other hand, vaccina-
tion of offspring is not used to the same extent in Denmark as 
in other EU countries with a similar pig production. There may 
be different explanations for this—one is the extended use of a 
controlled program for specific pathogen-free (SPF) production 
of piglets. However, the use of several vaccines has been on the 
increase lately, especially since “the Yellow Card Scheme” was 
adopted by the Danish Veterinary Authorities (2).
In Danish pig production, the majority of antimicrobials are 
used for treatment of gastrointestinal and respiratory indications 
in weaner pigs from 7–30 kg, followed by treatment of gastroin-
testinal indications in finishing pigs (VetStat data, unpublished). 
Mycoplasma hyopneumoniae (MYC), porcine circovirus type II 
(PCV2), Actinobacillus pleuropneumoniae (APP), porcine repro-
ductive and respiratory syndrome (PRRS) virus, and Lawsonia 
intracellularis (LAW) represent some of the most important 
disease agents related to these indications, which are also prevent-
able through vaccination of breeding animals and/or offspring.
Mycoplasma hyopneumoniae is a bacterium causing enzootic 
pneumonia in pigs. Enzootic pneumonia is most often seen in 
finishing pigs, where it is associated with productivity losses. 
The  bacteria are considered to be present in all Danish con-
ventional pig herds and in 67% of SPF herds (5). MYC in itself 
does not necessarily cause disease problems in infected herds. 
However, associated secondary infections may aggravate clinical 
signs, and increase the need for treatment (6). Vaccination against 
MYC would, therefore, be expected to reduce the need for anti-
microbial treatment. The effect of vaccination against MYC has 
previously been shown to have a positive effect on growth and 
reduced lung lesions (7–9). There are several vaccines against 
MYC available on the Danish market. MYC corresponded to 36% 
of the vaccine dosages prescribed in 2013, being, therefore, the 
most frequently used type of vaccine in pig production (10).
Porcine circovirus type II is a virus associated with several 
different clinical signs in pigs. The virus is considered present in 
nearly all Danish pig herds, without necessarily causing disease 
problems. Previously, the main disease problem related to PCV2 
in Danish pig production was postweaning multisystemic wast-
ing syndrome (PMWS) in weaner pigs. Nowadays, problems are 
mainly related to reduced growth and increased mortality in 
finishing pigs. PCV2 has an immuno-suppressive effect, which 
potentiates the impact of other pathogens, resulting in a need 
for antimicrobial treatment (11). Therefore, vaccination against 
PCV2 could potentially reduce disease occurrence and, conse-
quently, the use of antimicrobials. In fact, after the adoption of 
the Yellow Card Scheme, a 31% increase in the use of PCV2-
vaccines was seen over 1  year in Danish pig production (2). 
Vaccination against PCV2 has been shown to result in increased 
growth rate and reduced mortality in finishers (12), as well as 
reduced antimicrobial use (13, 14). Vaccines against PCV2 are 
the second most frequently used group of vaccines in Danish pig 
production, representing 26% of the vaccine dosages prescribed 
in 2013 (10).
Actinobacillus pleuropneumoniae is a bacterium causing 
pleuropneumonia in pigs and is associated with reduced growth 
and increased mortality, primarily in finishing pigs. There are 15 
different serotypes producing a combination of two or more of 
the four toxins responsible for the pathology leading to disease in 
pigs (15). The most prevalent serotypes in Denmark are serotypes 
2, 5, 6, 5, and 7. Most SPF herds are free from APP. However, 
serotype 6 is present in 26% of SPF herds, serotype 2 in 17%, 
serotype 7 in 0.4%, and serotype 5 in 0.1% (5). Studies have shown 
that vaccines against APP can reduce the prevalence of pleuritis 
(16, 17). Vaccines against APP are the third most frequently used 
type of vaccines in Danish pig production, representing 8% of the 
vaccine dosages prescribed in 2013 (10). It could be expected that 
preventing APP by using vaccination would reduce the treatment 
of this bacterial infection.
only minor effects were found, when vaccinations were used in combination. In conclu-
sion, this study provided little support for the hypothesis that vaccination against five 
common endemic diseases provides a plausible general strategy to reduce antimicrobial 
use in Danish pig herds.
Keywords: antimicrobial, vaccination, pig production, Mycoplasma hyopneumoniae, porcine circovirus type ii, 
Actinobacillus pleuropneumoniae, porcine reproductive and respiratory syndrome virus, Lawsonia intracellularis
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Porcine reproductive and respiratory syndrome virus 
multiplies in macrophages in the lungs, thereby making pigs 
more susceptible to bacterial infections, such as infections 
with Streptococcus suis (18). There are two different strains; the 
United States (US) strain and the European strain, which are 
both present in the Danish national pig herd. Among SPF herds, 
27% are infected with the US strain, whereas 20% are infected 
with the European strain. The two strains are causing similar 
clinical signs in pigs, mainly reproductive failure and respiratory 
distress (5). Vaccines against PRRS virus represent 2% of the vac-
cines dosages prescribed (10). The use of vaccines against PRRS 
in Denmark has been on a more or less constant lower level, 
compared to the use of vaccines against MYC, PCV2, and APP 
(VetStat data, unpublished). There are currently two modified-
live vaccines and two inactivated vaccines against PRRS on the 
Danish market (19).
Lawsonia intracellularis is one of the predominant agents 
responsible for the development of porcine proliferative enter-
opathy, resulting in diarrhea in weaner and finishing pigs (20). 
The herd-level prevalence of LAW in Danish herds is above 
90% (21), but the infection does not necessarily lead to clinical 
disease. Still, substantial amounts of antimicrobials are used 
for the treatment of gastrointestinal indications in Danish pigs. 
Therefore, prevention of diarrhea caused by LAW is likely to lead 
to reduced use of antimicrobials. There is currently only one 
vaccine available for prevention of LAW, and it accounted for 
3% of the vaccine dosages prescribed for pigs in 2013 (10). This 
implies that it is used to nearly the same extent as vaccines against 
PRRS, and the purchase of this vaccine has increased since 2010 
(VetStat data, unpublished). Previous studies have found reduced 
mortality and increased growth followed by vaccination against 
LAW (22), as well as reduced antimicrobial use (23).
Initiating vaccination in a herd represents an extra produc-
tion cost. Hence, it is important for the farmer to know the 
cost-efficiency of vaccines in different situations. Previous studies 
testing the effect of vaccines against MYC, PCV2, APP, PRRS, or 
LAW have mainly investigated the effect on production or health 
parameters. Few studies have investigated the effect of vaccina-
tion on antimicrobial usage, and usually, the effect has only been 
assessed in one farm at a time, not allowing for any generalization 
of results. A recent study by Temtem et al. (10) evaluated the effect 
of vaccines against MYC, PCV2, and LAW on antimicrobial use 
in 1,513 Danish pig farms, using a cross-sectional study design to 
compare the total amount of antimicrobials prescribed in 2013 in 
herds with and without vaccination against one or more of MYC, 
PCV2, and LAW. However, the date of initiation of vaccination 
and other possible important risk factors and confounders were 
not taken into account.
The objective of the present study was to estimate the effect 
of initiating vaccination against MYC, PCV2, APP, PRRS, and 
LAW on the change in antimicrobial prescription in weaner and 
finishing pigs at herd-level, while taking into account plausible 
associated risk factors and confounders. To evaluate whether 
eventual detected effects were actually related to vaccination 
rather than general trends in the target population, the change 
in antimicrobial prescription in vaccinating herds was compared 
to the change in antimicrobial prescription in randomly selected 
comparable periods for herds not vaccinating against the specific 
vaccine in question.
MaTerials anD MeThODs
herd enrollment
Full-line conventional pig herds were identified using yearly data 
extractions from the Central Husbandry Register (CHR) and 
quarterly extractions of movements between pig herds from the 
Danish Pig Movement Database. The following types of herds 
were identified and included (Figure 1):
• Type 1: farrow-to-finisher herds, which contained age groups 
Sows, Weaners, and Finishers registered under one CHR 
number (implying one geographical location). In order to be 
considered a farrow-to-finisher production, the number of 
Weaner and Finisher pen places had to be at least 1.5 times the 
number of sow pen places, indicating that at least part of the 
offspring remained in the herd until the finishing stage.
• Type 2: herds with age groups Sows, Weaners, and Finishers 
registered under one CHR number (source herd) and with 
movement of growing pigs to herds with age group Finishers 
(receiving herd).
• Type 3: herds with age groups Sows and Weaners registered 
under one CHR number (source herd) and with movement 
of growing pigs to herds with age group Finishers (receiving 
herd).
• Type 4: herds with age groups Sows, Weaners, and Finishers 
registered under one CHR number (source herd) and with 
movement of growing pigs to herds with age groups Weaners 
and Finishers (receiving herd).
• Type 5: herds with age groups Sows and Weaners registered 
under one CHR number (source herd) and with movement of 
growing pigs to herds with age groups Weaners and Finishers 
(receiving herd).
It was a requirement that each receiving herd only received 
pigs from one source herd in each quarter of a year, whereas 
source herds could deliver pigs to more than one finisher pig 
herd. Moreover, only source herds with a minimum of 100 
sow pen places and a minimum number of weaner pen places 
equal to or higher than 1.5 times the number of sow pen places 
were included, to make sure these herds were not sow-only or 
weaner-only. For receiving herds to be included, a minimum of 
100 finisher pen places was required.
Purchase of Vaccination
To study the effect of initiating vaccination against MYC, PCV2, 
APP, PRRS, and LAW, 10 different longitudinal studies were car-
ried out on historical data; for each vaccine group, one study was 
made on the effect on antimicrobial use in weaner and finishing 
pigs. Purchase of vaccines for Danish pig herds is recorded in 
the Danish VetStat Database (VetStat). Data used in this study 
were raw historical data from VetStat, retrieved on June 1, 2015. 
Purchase of all vaccine products against the five disease agents 
was extracted for the source herds. All herds with their first 
purchase of a vaccine under study between January 1, 2007, and 
FigUre 1 | illustration of the types of source herds included in the study, characterized by herd composition and types of pigs moved to other 
herds.
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December 31, 2013, were included. A sow herd was considered to 
have initiated vaccination in this period and was included in the 
analyses if it fulfilled the following criteria:
 1. No prior purchase of the vaccine in question either in the 
source herd or receiving herds from January 1, 2005.
 2. Purchase of the vaccine for at least 1 year following the first 
purchase.
 3. Purchase of more than a minimum threshold of vaccine doses 
per year per sow. The minimum of doses was determined 
based on evaluation of a histogram showing the distribution of 
vaccine coverage. The vaccine coverage was calculated as the 
number of doses in the first year of vaccination divided by the 
number of sows registered in the individual herd multiplied 
with 25, representing the average number of weaned pigs per 
sow per year in Denmark. For MYC and PCV2, the threshold 
was set at >0.5 and <1.5 corresponding to herds with a vaccine 
coverage between 50 and 150%. This large a margin around 
the 100% coverage was needed in order to include those herds 
representing the area on the histogram with the majority of 
the observations. For LAW, APP, and PRRS, the threshold was 
lowered in order to avoid too many herds being excluded due 
to this criterion. Therefore, only an upper threshold was set at 
<1.5.
Non-vaccinating herds were identified based on extraction of 
all active source herds in CHR with no purchase of the vaccine 
in question, at any time within the period between January 1, 
2005, and April 30, 2015. A herd was considered active when 
having recordings of antimicrobial prescriptions in VetStat for all 
quarters, in a period of 12 months before and 18 months after the 
first vaccine purchase.
For each analysis, information about purchase of the remain-
ing four types of vaccines within the period studied for each 
herd was included. For this, data on the general purchase of the 
vaccines in the period from January 1, 2005, until April 30, 2015, 
were extracted and summarized by quarter of the year, to be able 
to match correctly with the selected study period for each herd 
included. For a herd to be considered using other vaccines, the 
herd had to have purchased the given vaccine for at least 1 year 
in total and within at least one quarter of the study period for the 
individual herd.
antimicrobial Use
Herd-level antimicrobial prescription data extracted from the raw 
VetStat data were used in this study as a proxy for antimicrobial 
use. All prescriptions of antimicrobials, irrespective of indication 
for weaner and finishing pigs, were included in the study. For 
farrow-to-finisher herds, data on antimicrobial prescription 
for weaner and finishing pigs were extracted for the individual 
herd. For full-line herds identified using movement data, data on 
antimicrobial prescription for weaner pigs were extracted from 
the source herd, while for finishing pigs data were extracted from 
the receiving herds (Figure 1).
Antimicrobial data for weaner and finishing pigs were 
extracted for a period of 2.5 years. This consisted of data from 
1 year before vaccination was initiated, until 1.5 years after vac-
cination was initiated. The period of the first 6 months after vacci-
nation was initiated was considered a transition period, in which 
not all weaner and finishing pigs entering the stables had been 
vaccinated yet. Data from this period were excluded for the data 
analyses. Each prescription was converted into a number of ADD, 
using standardized doses per antimicrobial product developed by 
the Danish Veterinary and Food Administration. The ADD takes 
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into account a standard average weight of a weaner pig (15 kg) 
and a finishing pig (50 kg), as well as the total amount and dose 
of the antimicrobial prescribed. All prescriptions in ADD were 
divided into quarterly prescriptions for each herd, over the given 
period of 2.5 years selected for analysis. Each herd had to have 
prescriptions in each of the quarters within this study period, in 
order to be considered an active producing herd and, therefore, 
be included in the study. The number of weaner and finishing 
pigs in each herd at the time of vaccination was provided by data 
from the CHR. These numbers were used in the calculation of 
the average ADD per 100 weaners per day, and of ADD per 100 
finishers per day, in the 1-year period before (Baseline ADD) and 
6–18 months after vaccination was initiated (ADD After) in each 
herd. The change in amount of prescribed antimicrobials (Change 
in ADD) following initiation of vaccination was calculated for 
each herd by subtracting Baseline ADD from the ADD After.
For herds not vaccinating against a specific pathogen (e.g., APP, 
MYC, etc.), a random date was chosen in the same period as for 
the vaccinating herds (between January 1, 2007, and December 
31, 2013), and the same set-up was used around this date; anti-
microbial prescription during 1 year before the random date was 
included, followed by 6  months of data, which were excluded, 
and then data on antimicrobial prescription covering 1 year were 
included. Also, Change in ADD was calculated for these herds, 
which acted as a comparison group. It should be noted that, in the 
analyses, it was still taken into account whether these herds that 
were not exposed to the specific vaccine in question (e.g., MYC) 
were vaccinated against any of the other vaccines (i.e., PCV2, 
APP, PRRS, and/or LAW).
On rare occasions, prescription entry errors occur in the 
VetStat database, resulting in either negative or extreme values, 
when calculating ADD over a selected time period. When nega-
tive values of ADD were identified, the corresponding herd was 
excluded from the study. Also, a few herds with extremely high 
ADD values (>60 ADD/100 weaners/day and >20 ADD/100 fin-
ishers/day) were excluded, as these most likely reflected recording 
errors or dramatic unregistered changes in the herd population.
Description of Variables
In all models, the outcome variable was the Change in ADD, and 
this variable was included as a continuous variable after checking 
for linearity. Three variables were tested as potential explanatory 
variables for Change in ADD:
• Vaccination: categorical variable with two levels; “Yes” and 
“No,” representing vaccinating (exposed) and non-vaccinating 
(non-exposed) herds, respectively.
• Baseline ADD: continuous variable, representing a baseline 
measure of antimicrobial use. It was estimated as the anti-
microbial prescription 1 year before vaccination (or random 
date for the non-vaccinating group), in average ADD per 100 
animals per day, for weaned and finishing pig.
• Other vaccines: four categorical variables, one for each of the 
other four vaccines than the one under investigation in each 
study, with two levels; “Yes” and “No,” representing source 
herds that were or not using another vaccine when vaccination 
with the study-specific vaccine started.
In addition, five variables were included as potential 
confounders:
• Sows: the number of sows in the individual source herd was 
included as a continuous variable, representing the herd size.
• Year: the year of the first purchase of vaccine (or random 
date) was included as a categorical variable, representing the 
different changes and levels of antimicrobial use, which has 
been seen in Danish pig production between 2007 and 2013. 
After initial analyses with individual years, this variable was 
further grouped into “Before 2010” (<2010) and “After 2010” 
(≥2010), representing the period before and after the Yellow 
Card Scheme was implemented in Denmark.
• Season: because it is known that antimicrobial use can fluc-
tuate by season and a farmer may be more likely to initiate 
vaccination during seasons with high antimicrobial use, the 
season might confound the estimate of the effect of initiating 
vaccination. Therefore, the quarter of the year of the first pur-
chase of vaccine (or random date for non-vaccinating herds) 
was included, to account for season as a categorical variable 
with four levels; “1,” “2,” “3,” and “4,” representing the first to 
the fourth quarter of the year.
• SPF: categorical variable with two levels; “SPF” and “Non-SPF,” 
representing source herds enrolled or not in the SPF system 
at the time of vaccination (or random date), respectively. 
Information about enrollment of each herd in the Danish SPF 
system was provided by SEGES Pig Research Centre (SEGES). 
The SPF variable was used as a measure of herd health status 
and considered as a potential confounder, as herds in the SPF 
system might have a better health status than non-SPF herds, 
which may influence the antimicrobial use in those herds.
• Export: categorical variable with two levels; “Yes” and “No,” 
representing source herds with and without export of growing 
pigs, respectively. For each herd, information about exporting 
of animals was assessed using the Danish Pig Movement 
Database, which contains all movements of animals from 
Danish herds to other countries. Besides having moved 
animals from the source to the receiving herd, some of the 
herds had also exported either 7 or 30  kg weaner pigs to 
other countries. This information was included as a potential 
confounder in the analyses, as importers might demand that 
pigs are vaccinated against specific diseases, even if the Danish 
herd was not infected with the given disease agent.
Continuous variables were plotted against the outcome 
variable and against each other, to visually check for linearity and 
correlations. For categorical variables, distributions were checked 
for a reasonable number of observations in each variable level.
statistical analyses
All statistical analyses and data management were carried out 
using the software R version 3.1.3. Separate data analysis was 
conducted for each of the 10 models, representing the effect 
of the five types of vaccines in weaner and finishing pig herds. 
General linear regression models were used to model the Change 
in ADD for weaner pigs as a function of the potential explanatory 
variables and covariates.
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The same variables were used to model the Change in ADD 
for finishers in a linear mixed-effects model, using the lme4 
package in R (24). Source herd was included as a random effect 
to account for clustering of antimicrobial use patterns in herds 
with animals originating from the same source herd, and all other 
explanatory factors and covariates were included as fixed effects. 
First, univariable models between each explanatory variable and 
the outcome were assessed, and if associations showed P < 0.20, 
the variable was included in the multivariable model. However, 
to prevent misinterpretation in the face of poor data availability, 
if one of the stratified groups in a categorical variable contained 
fewer than five observations, the variable was not included in the 
multivariable model. The final multivariable model was identified 
by backwards-stepwise elimination of non-significant predictors, 
using the drop1-function in R. Significant two-way interactions 
of all main effects were checked one by one. The criterion for 
keeping a predictor or a two-way interaction in the model was 
P < 0.05, and models were compared using Akaike’s Information 
Criteria (AIC), with the AIC closest to 0 indicating the best 
model. Confounding was assessed by evaluating the models with 
and without each of the potential confounders. A variable was 
considered a confounder, if it changed the parameter estimates 
of any of the other significant variables by >20%. When an 
interaction between vaccination with the study-specific vaccine 
and one of the other vaccines was statistically significant, the two 
were recoded as a four-way variable, to be included in the final 
multivariable model, allowing for the estimation of the effect and 
significance of each category defined by the pairwise combina-
tion of vaccination statuses (Yes/Yes, No/No, Yes/No, No/Yes). 
The statistical significance of differences observed between the 
four categories was assessed with Tukey’s “Honest Significant 
Difference” method, using the multcomp package in R. The final 
models were presented with parameter estimates including SE 
and P-values, as well as the explanatory degree of the model.
The distribution of residuals was checked for normality using 
residual plots. The explanatory degree of the general linear regres-
sion models was assessed using the R2. ‘The explanatory degree’ 
of the mixed-effects models was assessed using the marginal 
pseudo-R2: (Re − Rfm)/Re, where Re is the residual variance of the 
model, only containing the random effect of source herd, and Rfm 
is the residual variance of the final model (25).
resUlTs
Descriptive statistics
There were small, characteristic differences between vaccinat-
ing and non-vaccinating herds, when looking at the descriptive 
statistics; for the majority of the studies, the Change in ADD was 
lowest and the Baseline highest in the vaccinating group. Also, 
the vaccinating groups consisted of larger herds, represented by 
the number of sows in the source herd, when compared to non-
vaccinating herds (Tables S1–S10 in Supplementary Material).
There were no substantial differences between the mean and 
median values for Change in ADD, Baseline ADD, and Sows. 
Therefore, it was chosen to present the mean. Overall, the mean 
Change in ADD was close to 0, but with a large range, especially 
for weaner pigs. As expected, the largest Baseline ADD was found 
among weaner pigs, with a nearly five times higher Baseline 
ADD than observed for finishers. The mean number of sows 
in the farrow-to-finisher and source herds only differed 1–7% 
between the studies on effect in weaner and finishing (Table S11 
in Supplementary Material). This happened because nearly the 
same source herds were used in the analyses for weaners and 
finishers for each type of vaccine.
For each of the 10 studies, there were between 71 and 334 
vaccinating source herds delivering pigs to between 89 and 365 
receiving herds. For the group of non-vaccinating herds, there 
were between 130 and 570 source herds delivering pigs to between 
158 and 662 receiving herds, in each of the studies.
analytical statistics
A summary of the main findings from each of the final regression 
models is presented in Table 1. Detailed results from the models 
can be found in Tables S12–S16 in Supplementary Material.
No study-specific vaccinations were found to have a signifi-
cant impact on the antimicrobial consumption, when analyzed 
independently. The baseline antimicrobial consumption before 
initiation of vaccination (Baseline ADD) was the only consist-
ently significant independent variable in all models, indicating 
that herds with a higher Baseline ADD obtained a larger reduc-
tion in ADD, when compared to herds with a lower Baseline 
ADD. The interaction between Baseline ADD and vaccination 
status was non-significant in all models, meaning that the effect of 
Baseline ADD was the same for herds initiating vaccination as for 
non-vaccinating herds. For those reasons, plots presented in this 
manuscript are based on the effect of Baseline ADD on Change 
in ADD, added with specific variables of interest, depending on 
the case (Figures 2 and 3).
For weaners, all five final models showed an effect of year, 
either as a direct effect or as interacting effect with Baseline ADD, 
while for finishers this was only the case for two of the five models 
(Table 1). The effect of year in all seven models showed that a 
larger decrease in ADD was seen after 2010, when compared to 
the period before 2010. The effect was the same, irrespective of 
vaccination status, since no interaction between year and vac-
cination was found in any of the models. The effect of Baseline 
ADD on Change in ADD according to year (when significant) is 
shown for all models in Figure 2.
The effect of initiating study-specific vaccinations was only 
significant in an interaction with the use of another vaccine in 
the same period for LAW and PRRS vaccination in finishers 
(Table  1). An increase in ADD was observed for herds using 
both LAW and PRRS, when compared to non-vaccinating herds 
(Figure  3; Table S16 in Supplementary Material). In addition, 
the use of APP vaccines had a positive effect on the Change in 
ADD for weaners in the PRRS-model, implying that a larger 
increase in ADD is seen in herds with use of APP vaccines. For 
the latter, there were no significant interaction between initiating 
vaccination against PRRS and using APP vaccines, which is why 
this effect was general for both vaccinating and non-vaccinating 
herds (Table 1; Table S15 in Supplementary Material).
The number of sows, representing herd size, was significantly 
associated with an increase in ADD in the PCV2 model for finish-
ers, as well as in the LAW and APP models for weaners. For the 
TaBle 1 | summarizeda results of the final linear regression models (weaners) and linear mixed models with random effects of potential confounders 
(finishers) predicting the change in antimicrobial consumption after initiation of vaccination in selected Danish swine herds between 2007 and 2013.
Vaccine age group statistically significant effects R2
Vaccine Baseline Other individual variables interactions
Mycoplasma hyopneumoniae Weaners No Yes Actinobacillus pleuropneumoniae (APP) 
vaccine
Baseline × year 0.25
MYC Finishers No Yes Specific pathogen-free No 0.27
Porcine circovirus type II (PCV2) Weaners No Yes Year No 0.27
Export
PCV2 Finishers No Yes Year No 0.24
Number of sows
APP Weaners No Yes Number of sows Number of 
sows × year
0.26
Baseline × year
APP Finishers No Yes No No 0.29
Porcine reproductive and respiratory syndrome 
(PRRS)
Weaners No Yes Year No 0.21
APP vaccine
PRRS Finishers No Yes No Baseline × year 0.24
Lawsonia intracellularis Weaners No Yes Number of sows Baseline × year 0.21
LAW Finishers Yesb Yes No Vaccine × PRRS 
vac.
0.30
aThe complete list of variables, coefficients, SE, and p-values for all models are shown in Tables S12–S16 in Supplementary Material.
bNon-significant as an isolated variable but significant as an interaction with another vaccine.
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latter model, the number of sows was only associated with an 
increase in ADD in the period before 2010, which was shown 
by the significant interaction between year and Sows (Table 1).
As for variables Export and SPF, the model estimates revealed 
that exporting herds had a larger increase in ADD for weaners 
than non-exporting herds in the PCV2-model (Table 1; Table S13 
in Supplementary Material). In the MYC model, SPF herds had a 
larger increase in ADD for finishers, when compared to Non-SPF 
herds (Table S12 in Supplementary Material). Again, these effects 
were the same, irrespective of vaccination status.
There was no confounding effect of any of the variables, and no 
effect of Season in any of the models. Each one of the final models 
explained 21–30% of the variation in the outcome variable.
DiscUssiOn
effect of Baseline and initiation 
of Vaccination
The objective of this study was to determine the effect of initiating 
vaccination against MYC, PCV2, APP, PRRS, and LAW on the 
Change in ADD for weaner and finishing pigs at herd level. We 
found that the Baseline ADD level had a persistent impact, being 
significant in all models and with more or less the same degree of 
impact on the Change in ADD for weaners as for finishing pigs. 
The effect of Baseline ADD in the models showed that, the higher 
the Baseline ADD in a herd, the larger the decrease in ADD seen 
over time. This was a general effect, regardless of vaccination, as 
the effect did not differ between vaccinating and non-vaccinating 
herds.
change in antimicrobial Use in Danish Pig 
herds
Overall, we found an average change in antimicrobial use around 
0, for both weaner and finishing pigs, regardless of vaccination 
status. Some herds experienced a decrease in ADD and, in gen-
eral, these herds had a high Baseline ADD. Other herds remained 
at a more or less constant level of ADD, or even increased in ADD 
over time. The latter were herds with an average or low Baseline 
ADD. Therefore, it seems reasonable that the Baseline ADD is an 
important variable to include, when looking at Change in ADD 
in individual pig herds. Still, the level of Baseline ADD and the 
level of Change in ADD in a herd are influenced by many other 
factors. As we see from the final models in this study, these two 
variables, although important, only explained between 1/4 and 
1/3 of the total variation of the observed Change in ADD in the 
herds included. This illustrates that Change in ADD in pig herds 
is a multifactorial and very complex measure.
One important factor to determine the Change in ADD must 
be disease occurrence. Producers experiencing disease problems 
will, in collaboration with the veterinarian, put in place measures 
to reduce disease and its consequences. This could result in a 
decrease in antimicrobial use over time. For vaccinating herds, 
the decrease observed in the present study was most likely due 
to the effect of vaccination. For non-vaccinating herds, other 
measures may have been used, such as type of feed, internal 
biosecurity (including ways of immunizing sows), and way of 
purchasing breeding animals.
Herds with no disease problems are at a constant risk of 
getting disease outbreaks. This is either due to the presence or 
FigUre 2 | continued
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introduction of various infectious disease agents, which can 
result in a sudden increase in antimicrobial use. The estimated 
change in antimicrobial use in pig herds over time, regardless 
of vaccination status, showed signs of regression toward the 
mean. This makes sense as, in population-based distributions, 
the conditional expectation of values located in the tails are 
FigUre 2 | Model-predicted associations between Baseline aDD (horizontal axis) and change in aDD (vertical axis), before (continuous line, based 
on black dots) and after (dashed line, based on grey dots) 2010, in groups of Danish swine herds that initiated vaccination or not against the five 
different endemic agents under study in 2007–2013. Each graph illustrates one model derived from vaccine- and production type-specific dataset. In models 
with only one (continuous) line, there was no significant effect of year, i.e. before vs. after 2010, in which the Yellow Card Scheme was initiated.
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typically closer to the overall mean, than to its observed value. 
Therefore, herds with high consumption are more likely to 
present a decrease, and herds with low consumption are more 
likely to increase.
An increase in ADD for vaccinating herds should not be 
interpreted as a missing effect of the vaccines. The increase may 
be a result of the increased occurrence of diseases other than 
the one being vaccinated against. In this study, we used the total 
ADD, since the validity of the different disease indications var-
ies, and some prescriptions do not have an indication assigned 
to it (VetStat data, unpublished). They would, therefore, not be 
included, if the ADDs were split into disease indications.
effect of restrictions from authorities
A reason for reducing antimicrobial use, other than mitigat-
ing disease in a pig herd, could be demands from authorities. 
In general, there has been much focus on reducing antimicrobial 
use in the general pig population in Denmark, as also seen in 
many other EU countries. Demands from Danish authorities 
increased after 2010, when the Yellow Card Scheme was imple-
mented, and an effect on the antimicrobial level was seen already 
from mid-2010, when permitted limits were announced (2). This 
effect can also be confirmed by the data included in this study, 
showing that the Change in ADD was affected by year (before and 
after 2010), especially in interaction with ADD Baseline. In the 
same period when the antimicrobial use decreased in Danish pig 
herds, an increased purchase of vaccines was observed, especially 
against MYC, PCV2, and APP. This probably reflects that some 
swine producers increased their use of vaccines, as an alternative 
to antimicrobial treatment.
There was no significant effect of interactions between initia-
tion of vaccination and year in any of the models, indicating 
FigUre 3 | Model-predicted associations between Baseline aDD per 100 finishers per day (horizontal axis) and change in aDD (vertical axis) in 
groups of Danish swine herds that initiated Lawsonia intracellularis vaccination or not, while also vaccinating or not against porcine reproductive 
and respiratory syndrome in 2007–2013.
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that the decrease in ADD seen after 2010 was not affected 
by initiation of vaccination. Still, some herds probably suc-
ceeded in reducing their antimicrobial consumption followed 
by initiation of vaccination (2). Other producers possibly 
adjusted their herd management, quality of feed, or level of 
biosecurity, in order to comply with the new restrictions. Some 
farmers probably also reduced their antimicrobial use of solely 
psychological reasons, by reducing their probability of getting 
a Yellow Card, if they were close to the Yellow Card limits. 
This kind of impact is difficult to determine and is out of the 
scope of this study.
effect of combination of Vaccines
It is generally believed that preventing several diseases through 
vaccination can have a larger effect, than the effect of preventing 
the sum of each of them. In this study, there was a significant effect 
of the interaction between initiating vaccination in combination 
with existing vaccine programs. This effect on ADD was observed 
for initiation of vaccination against LAW with concurrent use of 
PRRS vaccines in finishers (Figure 3). It was not expected that 
using two vaccines in combination would result in an increased 
Change in ADD, implying an increased use of ADD. This prob-
ably reflects that there was clinical disease due to these agents 
prior to the initiation of vaccination compared to the herds not 
vaccinating, resulting in an apparent missing effect of the vac-
cines due to reverse causality.
explanations for lack of effect of 
Vaccines
The lack of significant effect of vaccines on the antimicrobial use 
should not be interpreted as an indication of the vaccines not 
being effective. This study paid attention to the effect of initiation 
of vaccination, but it did not include long-term effects. Moreover, 
herds included in this study could have initiated vaccination for 
various reasons, which were unknown at the time of the study. 
Vaccines should prevent disease in individual animals but can 
also be used as a control measure at herd level.
Register data—as used here—include both herds with 
severe problems related to disease and herds in which vaccina-
tion is used as a preventive measure or required by the buyer. 
Producers who export 7 or 30  kg pigs to other countries sell 
their pigs for a higher price, if the pigs are vaccinated according 
to the requirements of the purchasing farmer. For farmers in 
Germany, this scenario is applicable, since it is a requirement 
that the pigs are vaccinated against PCV2. Exporting of pigs was 
included as a variable in each model but was only significant 
in the model testing the effect of initiating vaccination against 
PCV2 on the antimicrobial use in weaned pigs. It was shown that 
herds exporting weaned pigs had a larger increase in consump-
tion of antimicrobials than herds which do not. No significant 
effect of the interaction between Export and Vaccination was 
observed, so the effect was general for both vaccinating and 
non-vaccinating herds.
Vaccinating herds were compared to a group of herds, which 
did not use the vaccines in question during the study period. The 
reason for not using that vaccine could be that there was no need 
for it, meaning that non-vaccinating herds could be herds with 
better animal health, and therefore, it would be more difficult to 
obtain an effect of vaccination. In line with this, the antimicrobial 
use was likely a measure of disease, to some extent. However, high 
use in a Danish context (above 28 ADD per 100 weaners per day, 
and six ADD per 100 finishers per day) is not necessarily equal 
to substantial disease problems and poor pig health. Therefore, 
a positive effect of vaccination may be more difficult to see in 
the country, with a more visible increase in antimicrobial use, 
since the Baseline is already at a low level, when compared to 
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many other EU countries (26). In the study by Raith et al. (14), 
a significant decline in the use of antimicrobials was found after 
initiation of the PCV2 vaccine program in Austrian pig herds. 
However, herds in that study reduced their antimicrobial use 
to a level that would be considered high, in a Danish context 
(0.56 ADDkg/kg/year, corresponding to 7.7 ADD/100 animals 
per day, for finishing pigs). Again, this illustrates the impact of 
the Baseline ADD, which should always be taken into account, 
when looking at Change in ADD and the effect of vaccination on 
antimicrobial use.
Temtem et  al. (10) found the same lack of effect, or even 
apparent reverse causality, between vaccination and antimi-
crobial use. Even though we have taken more information into 
account, resulting in models with a higher explanatory degree, 
there is still some variance that cannot be explained with the 
available variables and models. This variance could reflect some 
psychologically based reasons, which are not directly measurable. 
Using vaccines in a herd may represent a different mindset of 
the producer or the responsible veterinarian, compared to herds 
not using vaccines. Producers using vaccines may have a general 
higher perception of the necessity to control and prevent diseases. 
For a producer, the use of vaccines and antimicrobials, probably 
in combination, might be the best way of having a successful 
production with fewer and less sick animals. This could also be 
influenced by some veterinarians being more likely to suggest the 
use of vaccines than others.
Data availability
Denmark is a country with a large pig production. Only a propor-
tion of Danish pig herds were included in this study, due to differ-
ent reasons and criteria. Some herds initiated vaccination before 
the beginning of the study period in 2007 and were, therefore, 
not included in the study. Only herd types allowing us to follow 
the pigs from vaccination in the sow herd, through weaning and 
finishing, were selected for this study. Other types of herds, for 
example herds with only one age group registered, also vaccinated 
against the five agents of interest within the study period. But for 
these types of herds, it would have been impractical to trace back 
and forth the vaccine dosages and antimicrobial prescriptions 
to include. The sample of herds included here covered around 
50–70% of all Danish vaccinating herds, depending on the study 
(VetStat data, unpublished).
Some herds were excluded due to extreme or negative values. 
These could have been further investigated, but that would 
require a large amount of time-consuming manual work, to 
identify and correct the reason for these outliers. Only a few 
percent of the total number of herds were excluded in each study, 
due to extreme or negative values. Hence, this should not have 
biased the results.
In the present study, it was necessary to loosen up on the 
criterion regarding number of vaccine doses purchased. Not 
many herds would have been included in the study testing effect 
of APP, PRRS, and LAW, if the same criteria were used as for the 
study testing effect of MYC and PCV2. This may reflect that these 
vaccines are applied differently in Danish pig herds. This could, 
for example, reflect the use of vaccines for other age groups than 
what they are licensed for. Another explanation could be the use 
of half dosages, or not using the vaccine continuously throughout 
the year. We knew that herds included in the study had purchased 
vaccines for at least 1 year, but it was difficult to get more informa-
tion than that, besides the number of doses purchased and the 
number of animals expected to be vaccinated. Again, this could 
also explain the missing effect of initiating vaccination against 
these agents.
cOnclUsiOn
This study provided little support for the hypothesis that vaccina-
tion against five common endemic diseases provides a plausible 
strategy to reduce antimicrobial use in Danish pig herds, overall 
speaking. Still, vaccination can be an asset in some situations.
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